Edition:
United Kingdom

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

9.45USD
6:20pm BST
Change (% chg)

$0.01 (+0.11%)
Prev Close
$9.44
Open
$9.42
Day's High
$9.63
Day's Low
$9.23
Volume
22,109
Avg. Vol
70,528
52-wk High
$20.97
52-wk Low
$9.23

Jaeger, Wilfred 

Dr. Wilfred E. Jaeger, M.D., is an Independent Director of Concert Pharmaceuticals Inc. Dr. Jaeger is director of the company. Dr. Jaeger has served as a member of our board of directors since May 2006. Dr. Jaeger co-founded Three Arch Partners, a venture capital firm, in 1993 and has served as a Partner since that time. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. He is also a member of the board of directors of Threshold Pharmaceuticals, Inc., a public pharmaceutical company, as well as numerous private companies. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, his M.D. from the University of British Columbia School of Medicine and an M.B.A. from Stanford University. In addition to representing one of our principal stockholders, we believe that that Dr. Jaeger’s financial and medical knowledge and experience allows him to be a key contributor to our board of directors.

Basic Compensation

Total Annual Compensation, USD 50,220
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 90,720
Fiscal Year Total, USD 140,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

167,720

Roger Tung

3,430,850

Marc Becker

--

Nancy Stuart

1,947,300

Lynette Herscha

--

James Cassella,

1,960,240
As Of  31 Dec 2017